165
28
20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77714 | HBV-IN-37 | HBV | |
HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research. | |||
T36747 | HBV-IN-4 | ||
HBV-IN-4, a derivative of phthalazinone, functions as a potent, orally active inhibitor of HBV DNA replication, exhibiting an IC50 value of 14 nM. It effectively induces the formation of genome-free capsids, demonstratin... | |||
T63852 | HBV-IN-8 | ||
HBV-IN-6 is a potent inhibitor of HBV (EC50: 287.9 nM). | |||
T63079 | HBV-IN-7 | ||
HBV-IN-6 is a potent inhibitor of HBV (EC50: 5 nM). | |||
T62247 | HBV-IN-9 | ||
HBV-IN-9 (example 20) is a potent inhibitor of HBsAg (HBV surface antigen) with an IC50 value of 10 nM. HBV-IN-9 (example 20) is also an inhibitor of HBV DNA replication with an IC50 value of 0.15 nM. | |||
T62466 | HBV-IN-17 | ||
HBV-IN-17 (compound 8) is a potent regulator of HBV capsid assembly (EC50: 511 nM). | |||
T61886 | HBV-IN-16 | ||
HBV-IN-16 is a quinoline derivative, which has an effective inhibitory effect on covalent closed circular DNA (cccDNA). CccDNA is the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 ha... | |||
T79469 | HBV-IN-34 | HBV | |
HBV-IN-34 (compound 17i) is a potent inhibitor of HBsAg production, demonstrating remarkable in vitro anti-HBV efficacy with EC50 values of 0.018 μM for HBV DNA and 0.044 μM for HBsAg [1]. | |||
T78812 | HBV-IN-36 | HBV | |
HBV-IN-36 (also known as compound 42) is a hepatitis B virus (HBV) inhibitor with an IC50 of 2 μM, exhibiting anti-HBV activity characterized by an EC50 of 0.58 μM [1]. | |||
T73283 | HBV-IN-32 | ||
HBV-IN-32, a potent inhibitor of covalently closed circular DNA (cccDNA), exhibits significant anti-Hepatitis B Virus (HBV) activity by achieving an IC50 of 0.14 µM against HBsAg. Additionally, it impedes cell growth. | |||
T73282 | HBV-IN-31 | ||
HBV-IN-31, a potent inhibitor of covalently closed circular DNA (cccDNA), demonstrates significant anti-HBV activity by inhibiting cell growth and exhibiting an IC50 value of 0.13 µM for HBsAg. | |||
T62579 | HBV-IN-19 | ||
HBV-IN19 has inhibitory effects on hepatitis B virus (HBV) infection. HBV-IN19 inhibits HBsAg secretion and/or production and can be used in the study of HBV infection (e.g. chronic HBV infection). | |||
T62704 | HBV-IN-23 | ||
HBV-IN-23 (Compound 5k) is an inhibitor of HBV DNA replication (IC50: 0.58 μM). HBV-IN-23 inhibits drug-sensitive and drug-resistant strains. HBV-IN-23 induces apoptosis in HepG2 cells and exhibits anti-hepatocellular ca... | |||
T62626 | HBV-IN-12 | ||
HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.001 μM < EC50 ≤ 0.05 μM). HBV-IN-12 is anti-HBV DNA (0.001 μM < EC50 ≤ 0.02 μM). | |||
T78783 | HBV-IN-35 | HBV | |
Compound HBV-IN-35 (Compound 88) serves as an HBV inhibitor and exhibits anti-HBV activity in both mouse and human hepatocytes with EC50 values of 100 nM and 400 nM, respectively [1]. | |||
T62355 | HBV-IN-14 | ||
HBV-IN-14 is a pyridinopyrimidinone compound and a potent covalent closed-loop DNA (cccDNA) inhibitor. HBV-IN-14 has potential for the study of HBV infection. | |||
T79767 | HBV-IN-41 | HBV | |
HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1]. | |||
T61115 | HBV-IN-25 | ||
HBV-IN-25 is a novel chemical compound that acts as a potent HBV cccDNA reducer when administered orally. It exhibits significant anti-HBeAg potency and anti-HBV activity, with IC50 values of 0.58 μM and 1.15 μM, respect... | |||
T73249 | HBV-IN-15 | ||
HBV-IN-15, a flavone derivative, acts as a potent inhibitor of covalently closed circular DNA (cccDNA), which is crucial for viral RNA transcription and subsequent viral DNA production. This compound shows promise for re... | |||
T79879 | HBV-IN-38 | HBV | |
HBV-IN-38 (Example 193), an HBV DNA inhibitor with an EC50 value of ≤100 nM, serves as a research tool for investigating viral infections [1]. | |||
T73280 | HBV-IN-29 | ||
HBV-IN-29 (ex8), a flavone derivative, functions as a potent inhibitor of covalently closed circular DNA (cccDNA), which is essential for viral RNA transcription and subsequent viral DNA replication. This compound shows ... | |||
T73281 | HBV-IN-30 | ||
HBV-IN-30 (ex44), a flavone derivative, acts as a potent inhibitor of covalently closed circular DNA (cccDNA), which is essential for viral RNA transcription and subsequent viral DNA production. This compound shows promi... | |||
T63162 | HBV-IN-22 | ||
HBV-IN-22 (Compound LC5f) is an HBV DNA replication inhibitor that acts on both wild-type HBV (IC50: 0.71 μM) and drug-resistant HBV (IC50: 0.84 μM). | |||
T63795 | HBV-IN-6 | ||
HBV-IN-6 is a potent inhibitor of HBV (EC50: 44 nM). | |||
T62115 | HBV-IN-24 | ||
HBV-IN-24 (compound (2 S, 6S)-1a) is a potent inhibitor of HBV. HBV-IN-24 is a strong inhibitor of HBV DNA (EC50: 0.6 nM), HBsAg (EC50: 0.6 nM) and HBeAg (EC50: 4.6 nM). antiviral effect and was able to improve neurotoxi... | |||
T62467 | HBV-IN-18 | ||
HBV-IN-18 (Compound 3) is an HBV capsid assembly modulator (CpAM) (EC50: 2790 nM). | |||
T64260 | HBV-IN-20 | ||
HBV-IN-20 is a potent, orally active HBV inhibitor (EC50: 0.46 μM). HBV-IN-20 is a classical type II CpAM (core protein assembly regulator). | |||
T61558 | HBV-IN-21 | ||
HBV-IN-21 (Compound II-8b) is a potent inhibitor of HBV DNA replication, exhibiting an IC50 of 2.2 μM. It demonstrates a favorable binding affinity (K D = 60.0 μM) for the HBV 4 capsid protein, thereby enabling effective... | |||
T79650 | HBV-IN-40 | HBV | |
HBV-IN-40 (Compound 11826096), with an IC50 of 0.7 µM, serves as a potent HBV inhibitor and exhibits antiviral activity [1]. | |||
T62256 | HBV-IN-11 | ||
HBV-IN-11 is a potent inhibitor of HBsAg secretion (EC50: 0.46 μM). | |||
T62144 | HBV-IN-13 | ||
HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg). | |||
T62434 | HBV-IN-10 | ||
HBV-IN-10 is an isomer of compound 6 (WO2021204258A1). Compound 6 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.1 μM < EC50 ≤ 1 μM). | |||
T63937 | HBV-IN-19 TFA | ||
HBV-IN19 TFA inhibits the secretion and/or production of HBsAg and has an inhibitory effect on hepatitis B virus (HBV) infection and can be used in studies of HBV infection, including chronic HBV infection. | |||
T76533 | HBV Seq1 aa:63-71 | ||
HBV Seq1 aa:63-71 is the fragment of hepatitis B virus (HBV) [1] . | |||
T62433 | (5S,8R)-HBV-IN-10 | ||
(5S,8R)-HBV-IN-10 is an isomer of compound 6 (WO2021204258A1). Compound 6 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.1 μM< EC50≤1 μM). | |||
T76530 | HBV Seq2 aa:208-216 | ||
HBV Seq2 aa:208-216, a CD8 epitope peptide derived from HBsAg, is investigated within the context of the Large envelope protein from the Hepatitis B virus [1]. | |||
T76534 | HBV Seq1 aa:18-27 | ||
HBV Seq1 aa:18-27 is a hepatitis B virus (HBV) core antigen 18-27 peptide fragment [1] . | |||
T76532 | HBV Seq1 aa:93-100 | ||
HBV Seq1 aa:93-100 is a hepatitis B virus (HBV) core antigen 93-100 peptide fragment [1] . | |||
T76531 | HBV Seq2 aa:179-186 | ||
HBV Seq2 aa:179-186, a novel epitope located on the hepatitis B virus surface antigen, effectively serves as a motif for CTL response within the H-2b system following in vitro restimulation of primed T cells [1]. | |||
T76535 | HBV Seq1 aa:141-151 | ||
HBV Seq1 aa:141-151 is a peptide useful in the research of chronic hepatitis B virus (HBV) [1]. | |||
T76529 | HBV Seq2 aa:28-39 | ||
HBV Seq2 aa:28-39, a Hepatitis B surface antigen (HBsAg) peptide, specifically binds to Major Histocompatibility Complex (MHC) class I molecules, as evidenced in sources [1] [2]. | |||
T5832 | Besifovir | HBV | |
Besifovir, a parent drug converted by LB80380, further metabolizes to its active form, LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV). | |||
T11409 | GLP-26 | HBV | |
GLP-26 disrupts the encapsidation of pre-genomic RNA, causes nucleocapsid disassembly and reduces cccDNA pools. GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system (IC50=3 nM... | |||
T4475 | JNJ-632 | HBV | |
JNJ-632 is a hepatitis B virus (HBV) capsid assembly modulator. | |||
T20048 | Vidarabine phosphate | Antiviral | |
Vidarabine phosphate is an adenosine monophosphate analog. It is the monophosphate ester of VIDARABINE. It also has antiviral and possibly antineoplastic properties. | |||
TQ0017 | AB-423 | HBV | |
AB-423 is an inhibitor of HBV capsid assembly, and potently inhibits HBV replication (EC50/EC90: 0.08-0.27 μM/0.33-1.32 μM in cells). | |||
T3449 | Bay 41-4109 racemate | HBV | |
BAY 41-4109 racemate is a potent inhibitor of human hepatitis B virus (HBV) with an IC50 of 53 nM. | |||
T4121 | Bicyclol | SY801 | HBV , Autophagy |
Bicyclol (SY801)(SY 801) is an anti-hepatitis drug. Oral administration of bicyclol normalizes the elevated serum transaminases (ALT, AST) by 50% in chronic viral hepatitis B and C, and also has a certain level of inhibi... | |||
T9225 | Vebicorvir | ABI-H0731 | HBV |
Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor, has demonstrated effective antiviral activity. | |||
T0044 | Oxethazaine | Oxetacaine | HBV , Sodium Channel |
Oxethazaine (Oxetacaine), a topical anesthetic, is used to prevent acid-induced esophageal pain. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN1482 | Chamaechromone | P450 , HBV | |
Chamaechromone is a natural product isolated from the roots of Stellera chamaejasme L.. Chamaechromone has anti-HBV and insecticidal activity. | |||
T4S1718 | Punicalin | HBV , HIV Protease | |
Punicalin exerts anti-inflammatory, antioxidative, and anti-hepatotoxic activities, it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner, with an IC50 of 0.11 microg/ml (0.14 microM). | |||
T3S0872 | Paederoside | Antiviral , HBV | |
1. Paederoside is a potent deterrent against the beetle was isolated from the aphid . 2. Paederoside displays high anti-tumor promoting activity against the Epstein-Barr virus activation. | |||
T3273 | Bifendate | Bifendatatum | HBV , Reverse Transcriptase |
Bifendate (Bifendatatum) is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug-induced liver injury. | |||
TQ0248 | Alisol F | HBV | |
Alisol F is a natural product from Alisma plantago-aquatica Linn and has many activities. | |||
T5S2254 | Swertianolin | Bellidifolin-8-O-Glucoside | Others , HBV , Antibacterial , AChE |
1. Swertianolin (Bellidifolin-8-O-Glucoside), mangiferin, rhodenthoside A-C, isoorientin, isovitexin, and amarogentin would serve as potential chemotaxonomic markers to differentiate Gentianaceae species. 2. Swertianolin... | |||
T3921 | Punicalagin | SARS-CoV , HBV | |
Punicalagin is a major ellagitannin found in pomegranates that is reported to produce antioxidant, anti-inflammatory, and anticancer effects. It has been shown to prevent high-fat diet-induced obesity-associated accumula... | |||
T2780 | Catalpol | Catalpinoside,Digitalis purpurea L | Others , HBV |
Catalpol (Catalpinoside) is an iridoid glycoside with neuroprotective, anti-inflammatory, and anti-hepatitis virus effects. | |||
T1922 | Pseudolaric Acid B | Apoptosis , p38 MAPK , Ferroptosis , HBV , Autophagy , Antifungal | |
Pseudolaric acid B, a natural diterpenoid compound, is isolated from Pseudolarix kaempferi. | |||
T3815 | Isoscopoletin | 7-Methoxyesculetin,6-Hydroxy-7-methoxycoumarin | Others , HBV |
Isoscopoletin (7-Methoxyesculetin) is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 6, 7-dimethoxy-2h-chromen-2-one. | |||
T2848 | Osthole | Osthol,NSC 31868,Ostol | Apoptosis , HBV , Parasite , Histamine Receptor |
Osthole (Osthol), a potential inhibitor of histamine H1 receptor, has been shown to stimulate osteoblast proliferation and differentiation. | |||
T5098 | Isochlorogenic acid A | 3,5-CQA,3,5-Dicaffeoylquinic acid | Reactive Oxygen Species , HBV , Endogenous Metabolite |
Isochlorogenic acid A (3,5-Dicaffeoylquinic acid), a natural phenolic acid, exhibits antioxidant and anti-inflammatory properties. | |||
T3750 | 4-Hydroxyacetophenone | 4-Acetylphenol,Piceol,p-Acetylphenol,4'-Hydroxyacetophenone | HBV , Xanthine Oxidase |
4-Hydroxyacetophenone (4-Acetylphenol) is a potent xanthine oxidase inhibitor. | |||
T0894 | Thiamine hydrochloride | Vitamin B1,Vitamin B1 hydrochloride,Thiamine HCl,Thiamine chloride hydrochloride | Apoptosis , HBV , Endogenous Metabolite |
Thiamine hydrochloride (Vitamin B1) is the hydrochloride salt form of thiamine, a vitamin essential for aerobic metabolism, cell growth, transmission of nerve impulses and acetylcholine synthesis. Upon hydrolysis, Thiami... | |||
T2S1158 | 4,5-Dicaffeoylquinic acid | 3,4-Dicaffeoylquinic acid,Isochlorogenic acid C | Others , HBV , Endogenous Metabolite |
1. 4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) has antiviral activity, including anti-HIV-1 integrase activity. 2. 4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) shows anti-hepatotoxic activity. | |||
T1020 | Doxorubicin hydrochloride | Adriamycin,Doxorubicin (Adriamycin) HCl,Hydroxydaunorubicin hydrochloride,NSC 123127 | Apoptosis , Mitophagy , HBV , HIV Protease , Topoisomerase , Antibacterial , Antibiotic , AMPK , Autophagy |
Doxorubicin hydrochloride (Adriamycin) belongs to the anthracycline class of antibiotics and is an inhibitor of human DNA topoisomerase I/II (IC50=0.8/2.67 μM). Doxorubicin hydrochloride exhibits cytotoxicity and antitum... | |||
T1456 | Doxorubicin | Hydroxydaunorubicin,Adriamycin | Topoisomerase , AMPK |
Doxorubicin (Adriamycin) is a Topoisomerase II (Top2) inhibitor with antineoplastic activity. | |||
TN5845 | Neochlorogenic acid methyl ester | 5-O-Caffeoylquinic acid methyl ester,Methyl 3-caffeoylquinate,GIP (1-39) acetate(725474-97-5 Free base),Methyl neochlorogenate | Antioxidant , HBV |
Neochlorogenic acid methyl ester (5-O-Caffeoylquinic acid methyl ester) is derived from Artemisia capillaris and black chokeberry (Aronia melanocarpa) fruits. Neochlorogenic acid methyl ester shows weak anti-HBV activity... | |||
T3794 | Pentagalloylglucose | Penta-O-galloyl-β-D-glucose,1,2,3,4,6-O-Pentagalloylglucose,1,2,3,4,6-Penta-O-galloyl-beta-D-glucopyranose | Influenza Virus |
1, 2, 3, 4, 6-Pentagalloylglucose (Penta-O-galloyl-β-D-glucose) and gallic acid from Pistacia lentiscus have antimutagenic and antioxidant activities. 2. 1, 2, 3, 4, 6-Penta-O-galloyl-beta-D-glucose (PGG) possesses poten... | |||
T79975 | Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside | HBV | |
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside (Compound 1), a lignan with anti-HBV activity, exhibits selectivity by targeting the HBV surface antigen (HBsAg) with an IC50 of 0.58 mM, whereas its activity ag... | |||
T79976 | Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside | HBV | |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside serves as an anti-hepatitis B virus (anti-HBV) agent, effectively inhibiting the secretion of HBV surface antigen (HBsAg) and HBV e antigen (HBeAg) in the Hep G2.2... | |||
T81531 | Pedunculosumoside F | ||
Pedunculosumoside F, a homoflavonoid glucoside extracted from Ophioglossum pedunculosum, exhibits cytotoxicity against HepG2 22.15 cells, presenting a CC50 value of 56.7 μM, yet lacks anti-HBV activity. Conversely, its a... | |||
TN2188 | Schisanwilsonin B | Schisanwilsonin I | Others |
Schisanwilsonin D, and schisantherin C show anti-HBV activity. | |||
TN2220 | Sophoranol | (+)-Sophoranol | HBV |
(+)-Sophoranol exhibits antiviral activity against the Coxsackie virus B3. It also shows potent anti-HBV activity with an inhibitory potency against HBsAg secretion and against HBeAg secretion. | |||
TN3687 | Coclauril | HBV | |
Coclauril shows anti-Hepatitis B virus (HBV) activities, with EC50 values of 7.6 ± 0.5 ug/mL. | |||
TN1732 | Herpetone | HBV | |
Herpetone exhibits protective effects on CCl(4)-induced hepatocyte injury, it shows anti-hepatitis B virus (HBV) activity. | |||
TN4750 | Periglaucine A | HBV | |
Periglaucine A inhibits hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. | |||
TN4751 | Periglaucine B | HBV | |
Periglaucine B can inhibit hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05822 | Hepatitis B Virus (HBV)(ayw/France/Tiollais/1979) Capsid protein (His) | HBV-D | E. coli |
Hepatitis B virus (HBV) capsid assembly is a critical step in the propagation of the virus and is mediated by the core protein. The first cytoplasmic step in the formation of an infectious HBV virion is the formation of ... | |||
TMPH-00803 | HBV-A subtype adw2 (strain Rutter 1979) Capsid protein (His) | HBV-A | E. coli |
Self assembles to form an icosahedral capsid. Most capsids appear to be large particles with an icosahedral symmetry of T=4 and consist of 240 copies of capsid protein, though a fraction forms smaller T=3 particles consi... | |||
TMPH-00806 | HBV-D (isolate Germany/1-91/1991) Protein X (His & SUMO) | HBV-D | E. coli |
Multifunctional protein that plays a role in silencing host antiviral defenses and promoting viral transcription. Does not seem to be essential for HBV infection. May be directly involved in development of cirrhosis and ... | |||
TMPH-00808 | HBV-D subtype ayw (isolate Japan/JYW796/1988) Protein X (His) | HBV-D | E. coli |
Multifunctional protein that plays a role in silencing host antiviral defenses and promoting viral transcription. Does not seem to be essential for HBV infection. May be directly involved in development of cirrhosis and ... | |||
TMPH-00816 | HBV-A subtype adw2 (strain Rutter 1979) Large envelope protein (His) | HBV-A | in vitro E. coli expression system |
The large envelope protein exists in two topological conformations, one which is termed 'external' or Le-HBsAg and the other 'internal' or Li-HBsAg. In its external conformation the protein attaches the virus to cell rec... | |||
TMPH-00815 | HBV-A subtype adw2 (isolate Germany/991/1990) Capsid protein (His & Myc) | HBV-A | E. coli |
Self assembles to form an icosahedral capsid. Most capsids appear to be large particles with an icosahedral symmetry of T=4 and consist of 240 copies of capsid protein, though a fraction forms smaller T=3 particles consi... | |||
TMPH-00807 | HBV-D subtype ayw (isolate France/Tiollais/1979) Protein X (His & SUMO) | HBV-D | E. coli |
Multifunctional protein that plays a role in silencing host antiviral defenses and promoting viral transcription. Does not seem to be essential for HBV infection. May be directly involved in development of cirrhosis and ... | |||
TMPH-00804 | HBV-C subtype ayw (isolate China/Tibet127/2002) Capsid protein (Yeast, His) | HBV-C | Yeast |
Self assembles to form an icosahedral capsid. Most capsids appear to be large particles with an icosahedral symmetry of T=4 and consist of 240 copies of capsid protein, though a fraction forms smaller T=3 particles consi... | |||
TMPH-00805 | HBV-C subtype ayw (isolate China/Tibet127/2002) Capsid protein (E. coli, His) | HBV-C | E. coli |
Self assembles to form an icosahedral capsid. Most capsids appear to be large particles with an icosahedral symmetry of T=4 and consist of 240 copies of capsid protein, though a fraction forms smaller T=3 particles consi... | |||
TMPY-02702 | ASGR1 Protein, Human, Recombinant (His) | Human | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPY-05542 | ASGR1 Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPJ-00174 | TIM-3/KIM-3/HAVCR2 Protein, Mouse, Recombinant (aa 20-193, His) | Mouse | Human Cells |
T cell immunoglobulin and mucin domain-3 (TIM3), also called hepatitis A virus cellular receptor 2 (HAVCR2), is a transmembrane glycoprotein of the TIM family of immune regulating molecules and plays an important role in... | |||
TMPJ-00173 | TIM-3/KIM-3/HAVCR2 Protein, Mouse, Recombinant (aa 20-191, His) | Mouse | Human Cells |
T cell immunoglobulin and mucin domain-3 (TIM3), also called hepatitis A virus cellular receptor 2 (HAVCR2), is a transmembrane glycoprotein of the TIM family of immune regulating molecules and plays an important role in... | |||
TMPJ-00624 | TIM-3/KIM-3/HAVCR2 Protein, Marmoset, Recombinant (His) | Marmoset | Human Cells |
T cell immunoglobulin and mucin domain-3 (TIM3), also called hepatitis A virus cellular receptor 2 (HAVCR2), is a transmembrane glycoprotein of the TIM family of immune regulating molecules and plays an important role in... | |||
TMPY-05349 | ASGR1 Protein, Mouse, Recombinant (His), Biotinylated | Mouse | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPY-06943 | ASGR1 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPY-02193 | GOLPH2/GOLM1 Protein, Human, Recombinant (His) | Human | HEK293 |
Golgi membrane protein 1, also known as Golgi membrane protein GP73, Golgi phosphoprotein 2, and GOLM1, is a protein that belongs to the GOLM1 / CASC4 family. GOLM1 is widely expressed. It is highly expressed in the colo... | |||
TMPY-00671 | ASGR1 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
The asialoglycoprotein receptor (ASGPR), an endocytotic cell surface receptor expressed by hepatocytes, is triggered by triantennary binding to galactose residues of macromolecules such as asialoorosomucoid (ASOR). ASGPR... | |||
TMPY-04567 | SRPK1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus-Insect Cells |
Serine / threonine-protein kinase SRPK1, also known as SFRS protein kinase 1, Serine/arginine-rich protein-specific kinase 1, SR-protein-specific kinase 1 and SRPK1, is a cytoplasm and nucleus protein that belongs to the... | |||
TMPH-01556 | EIF2AK2 Protein, Human, Recombinant (His) | Human | Yeast |
IFN-induced dsRNA-dependent serine/threonine-protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the innate immune response to v... |